- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Advanced metastatic ovarian cancer
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 798KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 45KB)
Topotecan – July 2020
Topotecan: Solution concentrate for I.V. infusion 4 mg in 4 mL (as hydrochloride); Topotecan Accord®
Last updated
30 October 2020